- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/80 - Oxygen atoms
Patent holdings for IPC class C07D 239/80
Total number of patents in this class: 107
10-year publication summary
|
6
|
5
|
13
|
9
|
5
|
6
|
11
|
11
|
11
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4898 |
11 |
| Amgen Inc. | 4074 |
8 |
| Takeda Pharmaceutical Company Limited | 2713 |
3 |
| Curadev Pharma Pvt Ltd. | 21 |
3 |
| Curadev Pharma Limited | 9 |
3 |
| Edgewise Therapeutics, Inc. | 53 |
3 |
| Insilico Medicine IP Limited | 126 |
3 |
| Janssen Pharmaceutica N.V. | 3392 |
2 |
| Abbvie Inc. | 1800 |
2 |
| Biogen MA Inc. | 894 |
2 |
| Ideaya Biosciences, Inc. | 119 |
2 |
| Japan Tobacco Inc. | 3597 |
2 |
| Nihon Nohyaku Co., Ltd. | 327 |
2 |
| Shionogi & Co., Ltd. | 854 |
2 |
| Vifor (International) AG | 142 |
2 |
| CAS Center for Excellence in Molecular Plant Sciences | 60 |
2 |
| Merck Sharp & Dohme LLC | 3748 |
2 |
| Indivior UK Limited (co.) | 6 |
2 |
| The Regents of the University of California | 19918 |
1 |
| Merck Sharp & Dohme Corp. | 2194 |
1 |
| Other owners | 49 |